Fluorometric high-throughput assay for measuring chlamydial neutralizing antibody.
Fluorometric high-throughput assay for measuring chlamydial neutralizing antibody.
复制标题
用于测量衣原体中和抗体的荧光高通量测定。
DOI:
10.1128/cvi.00460-12
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Caldwell,Harlan
中科院分区:
文献类型:
--
作者:
Southern,Timothy;Bess,Leah;Harmon,Jillian;Taylor,Lacey;Caldwell,Harlan
Chlamydia trachomatis is an obligate intracellular mucosotropic pathogen that causes human infections of global importance. C. trachomatis causes trachoma, the leading cause of preventable blindness worldwide, and is the most common cause of bacterial sexually transmitted disease. Although oculogenital infections are treatable with antibiotics, a vaccine is needed to control C. trachomatis infection. Ideally, a vaccine would provide coverage against most, if not all, naturally occurring antigenically distinct serovariants. The development of a subunit vaccine to prevent oculogenital disease could be advanced by identifying chlamydial antigens that elicit pan-neutralizing antibodies, particularly among infected human populations of known risk factors. There is currently no objective high-throughputin vitroassay to screen human sera for neutralization to aid in identification of these antigens. This report describes an objective, high-throughputin vitroassay that measures C. trachomatis-neutralizing antibodies. Antibody-mediated neutralization of chlamydial infection was performed in a 96-well microtiter format, and neutralization was quantified by immunostaining fixed cells followed by automated fluorometric analysis. This report shows that fluorometric analysis of C. trachomatis infection directly correlates to labor-intensive manual inclusion counts. Furthermore, this report shows that fluorometry can be used to identify C. trachomatis serovar- and serocomplex-specific neutralization. This objective, high-throughput analysis of serum neutralization is amenable to epidemiological studies of human chlamydial infection, human clinical vaccine trials, and preclinical animal model experiments of Chlamydia infection.
登录
查看更多内容
DOI:
--
发表时间:
1976
期刊:
The Lancet
影响因子:
--
作者:
A. Segal;R. Arnot;M. L. Thakur;J. Lavender
通讯作者:
J. Lavender
DOI:
--
发表时间:
1965
期刊:
影响因子:
--
作者:
D. L. Wilhelm
通讯作者:
D. L. Wilhelm
DOI:
10.1016/0047-0740(80)90107-2
发表时间:
1980
期刊:
International journal of nuclear medicine and biology
影响因子:
--
作者:
M. Tsan;U. Scheffel;K. Tzen;E. Camargo
通讯作者:
E. Camargo
影响因子:
9.3
作者:
J. McAfee;M. Thakur
通讯作者:
M. Thakur
DOI:
--
发表时间:
1974
期刊:
影响因子:
--
作者:
C. Kozma;W. Macklin;L. M. Cummins;R. Mauer
通讯作者:
R. Mauer